The import of contraceptives to the US in 2023 stood at an estimated 2.415 billion USD. Forecasted data shows a consistent upward trend, with imports expected to reach approximately 2.9714 billion USD by 2028. The year-on-year increase is projected to be around 4.5% to 5% over this period, indicating steady growth. Over the five-year horizon, the compound annual growth rate (CAGR) is approximately 4.25%.
Future trends to watch for include:
- Shifts in regulatory policies affecting import dynamics.
- Technological advancements in contraceptive products driving demand.
- Increasing consumer awareness and access contributing to market expansion.
